Overweight Clinical Trial
Official title:
Treating Obesity and Its Consequences in Underserved Overweight Populations
Obesity has reached epidemic proportions with nearly two-thirds of the US population either overweight or obese. Thus, novel strategies that both improve weight loss maintenance and are accessible to those most in need are the focus of this application, which will determine if a telemedicine system can help participants, who have undergone a weight loss program based in church and community centers, maintain their weight loss over a 1 year period. Telemedicine will provide support through self-monitoring, education, supervised chat room, bulletin board, and e-mail.
Obesity has reached epidemic proportions with nearly two-thirds of the US population either
overweight or obese. Ethnic minorities are disproportionately affected with 37% of
African-American adults being obese. Obesity is also inversely related to socioeconomic
status. In Pennsylvania, the prevalence of obesity increased from 14.7% in 1991 to 24.0% in
2002, and annual medical expenditures attributable to obesity are estimated at $4.2 billion;
making Pennsylvania the 4th highest state in the country in terms of obesity-related costs.
The prevalence of obesity is matched by it serious medical consequences including type 2
diabetes, hypertension, dyslipidemia, and atherosclerotic disease. The core pathogenetic
factor underlying these conditions appears to be insulin resistance. Weight loss through
diet and physical activity is the most desirable way to reduce insulin resistance (IR).
Weight losses of 8-10% are associated with significant improvements in IR. While
clinic-based weight loss programs at tertiary medical centers can produce clinically
significant losses, the cost and location of these programs make them inaccessible to
underserved populations (e.g., inner city African Americans and rural poor) who are most in
need. Moreover, the most common outcome for weight loss treatments is weight regain. Thus,
novel strategies that both improve weight loss maintenance and are accessible to those most
in need are a priority for research and the focus of this application.
Based on our expertise in behavioral weight management and telemedicine, this study will
determine if a telemedicine system can help participants, who have undergone a weight loss
program based in church and community centers, maintain their weight loss over a 1 year
period. Overweight and obese men and women (n = 400) will participate in a 16-week
behavioral weight loss program in local churches and community centers. After 16 weeks,
participants will be randomized to either an "In-person" follow-up group or to a
"telemedicine" group for 1-year. The latter will provide support through self-monitoring,
education, supervised chat room, bulletin board, and e-mail. Assessments of body weight,
body composition and insulin sensitivity will be conducted at baseline, 16 and 68 weeks.
Based on recent data, we predict greater maintenance of weight loss (and lower body weights)
at 68 weeks in the Telemedicine group as compared to the "In person group".
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT02829229 -
Community-based Obesity Treatment in African American Women After Childbirth
|
N/A | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |